创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Explaining the Features and Value of the FACS Platform

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-06-14 15:19
  • Views:

(Summary description)With its leading-edge flow cytometry (FACS) technology platform, InnoModels Biotechnology offers unprecedented solutions for research, drug discovery, immunotherapy, and clinical diagnostics, etc. The FACS platform, with its unique advantages, enables researchers to analyze cells more efficiently and accurately, thus advancing the development of bioscience.

InnoModels Biotechnology: Explaining the Features and Value of the FACS Platform

(Summary description)With its leading-edge flow cytometry (FACS) technology platform, InnoModels Biotechnology offers unprecedented solutions for research, drug discovery, immunotherapy, and clinical diagnostics, etc. The FACS platform, with its unique advantages, enables researchers to analyze cells more efficiently and accurately, thus advancing the development of bioscience.

  • Categories:Company news
  • Author:InnoModels
  • Origin:InnoModels
  • Time of issue:2024-06-14 15:19
  • Views:
Information

With its leading-edge flow cytometry (FACS) technology platform, InnoModels Biotechnology offers unprecedented solutions for research, drug discovery, immunotherapy, and clinical diagnostics, etc. The FACS platform, with its unique advantages, enables researchers to analyze cells more efficiently and accurately, thus advancing the development of bioscience.
One of the most notable features of the FACS platform is its highly flexible multi-parameter analysis. The platform utilizes a multi-channel laser and fluorescent label detection system that enables researchers to simultaneously analyze multiple cellular markers in a single experiment. This capability provides researchers with a more comprehensive and in-depth characterization of cells, which helps to more accurately understand the biology of cells, and thus advances scientific research. Whether in immunophenotyping, cell cycle studies, or stem cell research, FACS technology can play an important role.
In addition, the FACS platform has demonstrated a wide range of applications. Whether it is basic science research, drug development and immunotherapy, the platform provides strong support. Its instruments and kits are designed to take into account the needs of various cell types and research directions, thus providing researchers with a wealth of options. By working closely with customers, InnoModels Biotechnology is also able to provide customized solutions to meet the needs of research projects in different fields.

 


On the basis of the FACS platform, InnoModels Biotechnology has also developed a cell-based in vitro assay platform, which demonstrates unique advantages in microbial detection. The platform is capable of quickly and accurately identifying microorganisms such as bacteria, viruses and fungi, and is easy to operate without the need for special skills and equipment. In addition, the platform is highly sensitive and accurate, so that even trace amounts of microorganisms will not be missed, thus avoiding false alarms or misjudgments. This allows the platform to have a wide range of applications in the medical field for disease treatment and monitoring, as well as in environmental protection and food safety.
Overall, with its highly flexible multi-parameter analysis, wide range of application areas, and unique in vitro detection capability, InnoModels' FACS platform provides strong support for bioscience research and technology applications. It not only provides researchers with more comprehensive and in-depth cell characterization tools, but also promotes the progress of bioscience research. Meanwhile, the platform also plays an important role in many fields such as disease treatment, environmental monitoring, food safety, etc., demonstrating its wide application value.
In the future, with the continuous development of bioscience and the advancement of technology, the FACS platform of InnoModels Biotechnology is expected to continue to play a greater role. Its accurate, efficient and comprehensive analytical capabilities, as well as its adaptability to different research fields, have made the platform an important position in the field of biological sciences. We expect that InnoModels Biotechnology will continue to innovate and improve its FACS platform to provide more and better solutions for bioscience research and applications.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司